APO Research

APO RESEARCH · REPORT

Fludeoxyglucose F 18 Injection

Selected research

Market Structure

Global Fludeoxyglucose F 18 Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Fludeoxyglucose F 18 Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Fludeoxyglucose F 18 Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Fludeoxyglucose F 18 Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Fludeoxyglucose F 18 Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Fludeoxyglucose F 18 Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Fludeoxyglucose F 18 Injection include China Isotope & Radiation Corporation, Hta Co., Ltd, Yantai Dongcheng Biochemicals Co.,Ltd., Shanghai Atom Kexing Pharmaceutical Co.,Ltd., HUAYI Technology, Guangdong Cyclotron Medical Science Co., Ltd, Siemens(PETNet) and Isologic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Fludeoxyglucose F 18 Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Fludeoxyglucose F 18 Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Fludeoxyglucose F 18 Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Fludeoxyglucose F 18 Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Fludeoxyglucose F 18 Injection Segment by Company

China Isotope & Radiation Corporation

Hta Co., Ltd

Yantai Dongcheng Biochemicals Co.,Ltd.

Shanghai Atom Kexing Pharmaceutical Co.,Ltd.

HUAYI Technology

Guangdong Cyclotron Medical Science Co., Ltd

Siemens(PETNet)

Isologic

Fludeoxyglucose F 18 Injection Segment by Type

<200 mCi/1mL

>300 mCi/1mL

200-300 mCi/1mL

Fludeoxyglucose F 18 Injection Segment by Application

Heart Disease

Epilepsy

Cancer

Fludeoxyglucose F 18 Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fludeoxyglucose F 18 Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fludeoxyglucose F 18 Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fludeoxyglucose F 18 Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Fludeoxyglucose F 18 Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Fludeoxyglucose F 18 Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Fludeoxyglucose F 18 Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Fludeoxyglucose F 18 Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Fludeoxyglucose F 18 Injection Industry Trends Table 2. Fludeoxyglucose F 18 Injection Industry Drivers Table 3. Fludeoxyglucose F 18 Injection Industry Opportunities and Challenges Table 4. Fludeoxyglucose F 18 Injection Industry Restraints Table 5. Global Fludeoxyglucose F 18 Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Fludeoxyglucose F 18 Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Fludeoxyglucose F 18 Injection Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Fludeoxyglucose F 18 Injection Sales Market Share by Manufacturers Table 9. Global Fludeoxyglucose F 18 Injection Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Fludeoxyglucose F 18 Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Fludeoxyglucose F 18 Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Fludeoxyglucose F 18 Injection Manufacturers, Product Type & Application Table 13. Global Fludeoxyglucose F 18 Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Fludeoxyglucose F 18 Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of <200 mCi/1mL Table 17. Major Manufacturers of >300 mCi/1mL Table 18. Major Manufacturers of 200-300 mCi/1mL Table 19. Global Fludeoxyglucose F 18 Injection Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Fludeoxyglucose F 18 Injection Sales by Type (2021-2026) & (k units) Table 21. Global Fludeoxyglucose F 18 Injection Sales by Type (2027-2032) & (k units) Table 22. Global Fludeoxyglucose F 18 Injection Sales Market Share by Type (2021-2026) Table 23. Global Fludeoxyglucose F 18 Injection Sales Market Share by Type (2027-2032) Table 24. Global Fludeoxyglucose F 18 Injection Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Fludeoxyglucose F 18 Injection Revenue by Type (2021-2026) & (k units) Table 26. Global Fludeoxyglucose F 18 Injection Revenue by Type (2027-2032) & (k units) Table 27. Global Fludeoxyglucose F 18 Injection Revenue Market Share by Type (2021-2026) Table 28. Global Fludeoxyglucose F 18 Injection Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Heart Disease Table 30. Major Manufacturers of Epilepsy Table 31. Major Manufacturers of Cancer Table 32. Global Fludeoxyglucose F 18 Injection Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Fludeoxyglucose F 18 Injection Sales by Application (2021-2026) & (k units) Table 34. Global Fludeoxyglucose F 18 Injection Sales by Application (2027-2032) & (k units) Table 35. Global Fludeoxyglucose F 18 Injection Sales Market Share by Application (2021-2026) Table 36. Global Fludeoxyglucose F 18 Injection Sales Market Share by Application (2027-2032) Table 37. Global Fludeoxyglucose F 18 Injection Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Fludeoxyglucose F 18 Injection Revenue by Application (2021-2026) & (k units) Table 39. Global Fludeoxyglucose F 18 Injection Revenue by Application (2027-2032) & (k units) Table 40. Global Fludeoxyglucose F 18 Injection Revenue Market Share by Application (2021-2026) Table 41. Global Fludeoxyglucose F 18 Injection Revenue Market Share by Application (2027-2032) Table 42. Global Fludeoxyglucose F 18 Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Fludeoxyglucose F 18 Injection Sales by Region (2021-2026) & (k units) Table 44. Global Fludeoxyglucose F 18 Injection Sales Market Share by Region (2021-2026) Table 45. Global Fludeoxyglucose F 18 Injection Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Fludeoxyglucose F 18 Injection Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Fludeoxyglucose F 18 Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Fludeoxyglucose F 18 Injection Sales by Country (2021-2026) & (k units) Table 49. North America Fludeoxyglucose F 18 Injection Sales by Country (2027-2032) & (k units) Table 50. Europe Fludeoxyglucose F 18 Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Fludeoxyglucose F 18 Injection Sales by Country (2021-2026) & (k units) Table 52. Europe Fludeoxyglucose F 18 Injection Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Fludeoxyglucose F 18 Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Fludeoxyglucose F 18 Injection Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Fludeoxyglucose F 18 Injection Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Fludeoxyglucose F 18 Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Fludeoxyglucose F 18 Injection Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Fludeoxyglucose F 18 Injection Sales by Country (2027-2032) & (k units) Table 59. Global Fludeoxyglucose F 18 Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Fludeoxyglucose F 18 Injection Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Fludeoxyglucose F 18 Injection Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Fludeoxyglucose F 18 Injection Revenue Market Share by Region (2021-2026) Table 63. Global Fludeoxyglucose F 18 Injection Revenue Market Share by Region (2027-2032) Table 64. China Isotope & Radiation Corporation Company Information Table 65. China Isotope & Radiation Corporation Business Overview Table 66. China Isotope & Radiation Corporation Fludeoxyglucose F 18 Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. China Isotope & Radiation Corporation Fludeoxyglucose F 18 Injection Product Portfolio Table 68. China Isotope & Radiation Corporation Recent Development Table 69. Hta Co., Ltd Company Information Table 70. Hta Co., Ltd Business Overview Table 71. Hta Co., Ltd Fludeoxyglucose F 18 Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Hta Co., Ltd Fludeoxyglucose F 18 Injection Product Portfolio Table 73. Hta Co., Ltd Recent Development Table 74. Yantai Dongcheng Biochemicals Co.,Ltd. Company Information Table 75. Yantai Dongcheng Biochemicals Co.,Ltd. Business Overview Table 76. Yantai Dongcheng Biochemicals Co.,Ltd. Fludeoxyglucose F 18 Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Yantai Dongcheng Biochemicals Co.,Ltd. Fludeoxyglucose F 18 Injection Product Portfolio Table 78. Yantai Dongcheng Biochemicals Co.,Ltd. Recent Development Table 79. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Company Information Table 80. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Business Overview Table 81. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Fludeoxyglucose F 18 Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Fludeoxyglucose F 18 Injection Product Portfolio Table 83. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Recent Development Table 84. HUAYI Technology Company Information Table 85. HUAYI Technology Business Overview Table 86. HUAYI Technology Fludeoxyglucose F 18 Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. HUAYI Technology Fludeoxyglucose F 18 Injection Product Portfolio Table 88. HUAYI Technology Recent Development Table 89. Guangdong Cyclotron Medical Science Co., Ltd Company Information Table 90. Guangdong Cyclotron Medical Science Co., Ltd Business Overview Table 91. Guangdong Cyclotron Medical Science Co., Ltd Fludeoxyglucose F 18 Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Guangdong Cyclotron Medical Science Co., Ltd Fludeoxyglucose F 18 Injection Product Portfolio Table 93. Guangdong Cyclotron Medical Science Co., Ltd Recent Development Table 94. Siemens(PETNet) Company Information Table 95. Siemens(PETNet) Business Overview Table 96. Siemens(PETNet) Fludeoxyglucose F 18 Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Siemens(PETNet) Fludeoxyglucose F 18 Injection Product Portfolio Table 98. Siemens(PETNet) Recent Development Table 99. Isologic Company Information Table 100. Isologic Business Overview Table 101. Isologic Fludeoxyglucose F 18 Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Isologic Fludeoxyglucose F 18 Injection Product Portfolio Table 103. Isologic Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Fludeoxyglucose F 18 Injection Distributors List Table 107. Fludeoxyglucose F 18 Injection Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Fludeoxyglucose F 18 Injection Product Image Figure 2. Global Fludeoxyglucose F 18 Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fludeoxyglucose F 18 Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Fludeoxyglucose F 18 Injection Sales (2021-2032) & (k units) Figure 5. Global Fludeoxyglucose F 18 Injection Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Fludeoxyglucose F 18 Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. <200 mCi/1mL Image Figure 9. >300 mCi/1mL Image Figure 10. 200-300 mCi/1mL Image Figure 11. Global Fludeoxyglucose F 18 Injection Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Fludeoxyglucose F 18 Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Fludeoxyglucose F 18 Injection Sales Market Share by Type (2021-2032) Figure 14. Global Fludeoxyglucose F 18 Injection Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Fludeoxyglucose F 18 Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Fludeoxyglucose F 18 Injection Revenue Market Share by Type (2021-2032) Figure 17. Heart Disease Image Figure 18. Epilepsy Image Figure 19. Cancer Image Figure 20. Global Fludeoxyglucose F 18 Injection Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Fludeoxyglucose F 18 Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Fludeoxyglucose F 18 Injection Sales Market Share by Application (2021-2032) Figure 23. Global Fludeoxyglucose F 18 Injection Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Fludeoxyglucose F 18 Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Fludeoxyglucose F 18 Injection Revenue Market Share by Application (2021-2032) Figure 26. North America Fludeoxyglucose F 18 Injection Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Fludeoxyglucose F 18 Injection Sales Market Share by Country (2021-2032) Figure 28. U.S. Fludeoxyglucose F 18 Injection Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Fludeoxyglucose F 18 Injection Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Fludeoxyglucose F 18 Injection Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Fludeoxyglucose F 18 Injection Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Fludeoxyglucose F 18 Injection Sales Market Share by Country (2021-2032) Figure 33. Germany Fludeoxyglucose F 18 Injection Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Fludeoxyglucose F 18 Injection Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Fludeoxyglucose F 18 Injection Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Fludeoxyglucose F 18 Injection Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Fludeoxyglucose F 18 Injection Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Fludeoxyglucose F 18 Injection Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Fludeoxyglucose F 18 Injection Sales Market Share by Country (2021-2032) Figure 40. China Fludeoxyglucose F 18 Injection Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Fludeoxyglucose F 18 Injection Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Fludeoxyglucose F 18 Injection Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Fludeoxyglucose F 18 Injection Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Fludeoxyglucose F 18 Injection Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Fludeoxyglucose F 18 Injection Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Fludeoxyglucose F 18 Injection Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Fludeoxyglucose F 18 Injection Sales Market Share by Country (2021-2032) Figure 48. Brazil Fludeoxyglucose F 18 Injection Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Fludeoxyglucose F 18 Injection Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Fludeoxyglucose F 18 Injection Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Fludeoxyglucose F 18 Injection Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Fludeoxyglucose F 18 Injection Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Fludeoxyglucose F 18 Injection Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Fludeoxyglucose F 18 Injection Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Fludeoxyglucose F 18 Injection Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Fludeoxyglucose F 18 Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Fludeoxyglucose F 18 Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Fludeoxyglucose F 18 Injection Revenue (2021-2032) & (US$ Million) Figure 59. North America Fludeoxyglucose F 18 Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Fludeoxyglucose F 18 Injection Revenue (2021-2032) & (US$ Million) Figure 61. Europe Fludeoxyglucose F 18 Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Fludeoxyglucose F 18 Injection Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Fludeoxyglucose F 18 Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Fludeoxyglucose F 18 Injection Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Fludeoxyglucose F 18 Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Fludeoxyglucose F 18 Injection Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Fludeoxyglucose F 18 Injection Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • <200 mCi/1mL
  • >300 mCi/1mL
  • 200-300 mCi/1mL
Applications
  • Heart Disease
  • Epilepsy
  • Cancer
Companies covered
  • China Isotope & Radiation Corporation
  • Hta Co., Ltd
  • Yantai Dongcheng Biochemicals Co.,Ltd.
  • Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
  • HUAYI Technology
  • Guangdong Cyclotron Medical Science Co., Ltd
  • Siemens(PETNet)
  • Isologic

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Fludeoxyglucose F 18 Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Fludeoxyglucose F 18 Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Fludeoxyglucose F 18 Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Fludeoxyglucose F 18 Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Fludeoxyglucose F 18 Injection Market Dynamics
  1. 2.1 Fludeoxyglucose F 18 Injection Industry Trends
  2. 2.2 Fludeoxyglucose F 18 Injection Industry Drivers
  3. 2.3 Fludeoxyglucose F 18 Injection Industry Opportunities and Challenges
  4. 2.4 Fludeoxyglucose F 18 Injection Industry Restraints
3 Fludeoxyglucose F 18 Injection Market by Manufacturers
  1. 3.1 Global Fludeoxyglucose F 18 Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Fludeoxyglucose F 18 Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Fludeoxyglucose F 18 Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Fludeoxyglucose F 18 Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Fludeoxyglucose F 18 Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Fludeoxyglucose F 18 Injection Manufacturers, Product Type & Application
  7. 3.7 Global Fludeoxyglucose F 18 Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Fludeoxyglucose F 18 Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Fludeoxyglucose F 18 Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Fludeoxyglucose F 18 Injection Tier 1, Tier 2, and Tier 3
4 Fludeoxyglucose F 18 Injection Market by Type
  1. 4.1 Fludeoxyglucose F 18 Injection Type Introduction
  2. 4.1.1 <200 mCi/1mL
  3. 4.1.2 >300 mCi/1mL
  4. 4.1.3 200-300 mCi/1mL
  5. 4.2 Global Fludeoxyglucose F 18 Injection Sales by Type
  6. 4.2.1 Global Fludeoxyglucose F 18 Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Fludeoxyglucose F 18 Injection Sales by Type (2021-2032)
  8. 4.2.3 Global Fludeoxyglucose F 18 Injection Sales Market Share by Type (2021-2032)
  9. 4.3 Global Fludeoxyglucose F 18 Injection Revenue by Type
  10. 4.3.1 Global Fludeoxyglucose F 18 Injection Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Fludeoxyglucose F 18 Injection Revenue by Type (2021-2032)
  12. 4.3.3 Global Fludeoxyglucose F 18 Injection Revenue Market Share by Type (2021-2032)
5 Fludeoxyglucose F 18 Injection Market by Application
  1. 5.1 Fludeoxyglucose F 18 Injection Application Introduction
  2. 5.1.1 Heart Disease
  3. 5.1.2 Epilepsy
  4. 5.1.3 Cancer
  5. 5.2 Global Fludeoxyglucose F 18 Injection Sales by Application
  6. 5.2.1 Global Fludeoxyglucose F 18 Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Fludeoxyglucose F 18 Injection Sales by Application (2021-2032)
  8. 5.2.3 Global Fludeoxyglucose F 18 Injection Sales Market Share by Application (2021-2032)
  9. 5.3 Global Fludeoxyglucose F 18 Injection Revenue by Application
  10. 5.3.1 Global Fludeoxyglucose F 18 Injection Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Fludeoxyglucose F 18 Injection Revenue by Application (2021-2032)
  12. 5.3.3 Global Fludeoxyglucose F 18 Injection Revenue Market Share by Application (2021-2032)
6 Global Fludeoxyglucose F 18 Injection Sales by Region
  1. 6.1 Global Fludeoxyglucose F 18 Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Fludeoxyglucose F 18 Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Fludeoxyglucose F 18 Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Fludeoxyglucose F 18 Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Fludeoxyglucose F 18 Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Fludeoxyglucose F 18 Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Fludeoxyglucose F 18 Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Fludeoxyglucose F 18 Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Fludeoxyglucose F 18 Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Fludeoxyglucose F 18 Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Fludeoxyglucose F 18 Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Fludeoxyglucose F 18 Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Fludeoxyglucose F 18 Injection Revenue by Region
  1. 7.1 Global Fludeoxyglucose F 18 Injection Revenue by Region
  2. 7.1.1 Global Fludeoxyglucose F 18 Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Fludeoxyglucose F 18 Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Fludeoxyglucose F 18 Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Fludeoxyglucose F 18 Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Fludeoxyglucose F 18 Injection Revenue (2021-2032)
  8. 7.2.2 North America Fludeoxyglucose F 18 Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Fludeoxyglucose F 18 Injection Revenue (2021-2032)
  11. 7.3.2 Europe Fludeoxyglucose F 18 Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Fludeoxyglucose F 18 Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Fludeoxyglucose F 18 Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Fludeoxyglucose F 18 Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Fludeoxyglucose F 18 Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 China Isotope & Radiation Corporation
  2. 8.1.1 China Isotope & Radiation Corporation Company Information
  3. 8.1.2 China Isotope & Radiation Corporation Business Overview
  4. 8.1.3 China Isotope & Radiation Corporation Fludeoxyglucose F 18 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 China Isotope & Radiation Corporation Fludeoxyglucose F 18 Injection Product Portfolio
  6. 8.1.5 China Isotope & Radiation Corporation Recent Developments
  7. 8.2 Hta Co., Ltd
  8. 8.2.1 Hta Co., Ltd Company Information
  9. 8.2.2 Hta Co., Ltd Business Overview
  10. 8.2.3 Hta Co., Ltd Fludeoxyglucose F 18 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Hta Co., Ltd Fludeoxyglucose F 18 Injection Product Portfolio
  12. 8.2.5 Hta Co., Ltd Recent Developments
  13. 8.3 Yantai Dongcheng Biochemicals Co.,Ltd.
  14. 8.3.1 Yantai Dongcheng Biochemicals Co.,Ltd. Company Information
  15. 8.3.2 Yantai Dongcheng Biochemicals Co.,Ltd. Business Overview
  16. 8.3.3 Yantai Dongcheng Biochemicals Co.,Ltd. Fludeoxyglucose F 18 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Yantai Dongcheng Biochemicals Co.,Ltd. Fludeoxyglucose F 18 Injection Product Portfolio
  18. 8.3.5 Yantai Dongcheng Biochemicals Co.,Ltd. Recent Developments
  19. 8.4 Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
  20. 8.4.1 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Company Information
  21. 8.4.2 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Business Overview
  22. 8.4.3 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Fludeoxyglucose F 18 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Fludeoxyglucose F 18 Injection Product Portfolio
  24. 8.4.5 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Recent Developments
  25. 8.5 HUAYI Technology
  26. 8.5.1 HUAYI Technology Company Information
  27. 8.5.2 HUAYI Technology Business Overview
  28. 8.5.3 HUAYI Technology Fludeoxyglucose F 18 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 HUAYI Technology Fludeoxyglucose F 18 Injection Product Portfolio
  30. 8.5.5 HUAYI Technology Recent Developments
  31. 8.6 Guangdong Cyclotron Medical Science Co., Ltd
  32. 8.6.1 Guangdong Cyclotron Medical Science Co., Ltd Company Information
  33. 8.6.2 Guangdong Cyclotron Medical Science Co., Ltd Business Overview
  34. 8.6.3 Guangdong Cyclotron Medical Science Co., Ltd Fludeoxyglucose F 18 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Guangdong Cyclotron Medical Science Co., Ltd Fludeoxyglucose F 18 Injection Product Portfolio
  36. 8.6.5 Guangdong Cyclotron Medical Science Co., Ltd Recent Developments
  37. 8.7 Siemens(PETNet)
  38. 8.7.1 Siemens(PETNet) Company Information
  39. 8.7.2 Siemens(PETNet) Business Overview
  40. 8.7.3 Siemens(PETNet) Fludeoxyglucose F 18 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Siemens(PETNet) Fludeoxyglucose F 18 Injection Product Portfolio
  42. 8.7.5 Siemens(PETNet) Recent Developments
  43. 8.8 Isologic
  44. 8.8.1 Isologic Company Information
  45. 8.8.2 Isologic Business Overview
  46. 8.8.3 Isologic Fludeoxyglucose F 18 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Isologic Fludeoxyglucose F 18 Injection Product Portfolio
  48. 8.8.5 Isologic Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Fludeoxyglucose F 18 Injection Value Chain Analysis
  2. 9.1.1 Fludeoxyglucose F 18 Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Fludeoxyglucose F 18 Injection Production Mode & Process
  6. 9.2 Fludeoxyglucose F 18 Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Fludeoxyglucose F 18 Injection Distributors
  9. 9.2.3 Fludeoxyglucose F 18 Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research